Panacea Life Sciences Inc (OTCMKTS:PLSH) Stock Soars After Exclusive Manufacturing Agreement with Good Pharmaceutical Development Co.
Colorado, USA-based cannabinoid research and certified GMP manufacturing company, Panacea Life Sciences Inc (OTCMKTS:PLSH) on April 21, 2022, signed an exclusive product manufacturing agreement with Good Pharmaceutical Development Co. This agreement will lead to the production ofa proprietary, highly concentrated line of Remei CBD products for chronic pain. Trading Data On Thursday, PLSH stock moved up 41% to $0.55 with more than 11K shares traded, compared to its average volume…